These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1619 related articles for article (PubMed ID: 16151544)

  • 21. Linking genotype with phenotype in inflammatory bowel disease--Will we ever have reagent standard patients?
    Ghosh S
    Dis Markers; 2000; 16(3-4):167-71. PubMed ID: 11381201
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of inflammatory bowel disease classification changes on NOD2 genotype-phenotype associations in a population-based cohort.
    Gearry RB; Roberts RL; Burt MJ; Frampton CM; Chapman BA; Collett JA; Shirley P; Allington MD; Kennedy MA; Barclay ML
    Inflamm Bowel Dis; 2007 Oct; 13(10):1220-7. PubMed ID: 17538984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms and efficacy of immunobiologic therapies for inflammatory bowel diseases.
    Ghosh N; Chaki R; Mandal V; Lin GD; Mandal SC
    Int Rev Immunol; 2010; 29(1):4-37. PubMed ID: 20100080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology, genes and inflammatory bowel diseases in childhood.
    de Mesquita MB; Civitelli F; Levine A
    Dig Liver Dis; 2008 Jan; 40(1):3-11. PubMed ID: 17997369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with disease evolution in Greek patients with inflammatory bowel disease.
    Chatzicostas C; Roussomoustakaki M; Potamianos S; Paspatis G; Mouzas I; Romanos J; Mavrogeni H; Kouroumalis E
    BMC Gastroenterol; 2006 Jul; 6():21. PubMed ID: 16869971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of novel predictor classifiers for inflammatory bowel disease by gene expression profiling.
    Montero-Meléndez T; Llor X; García-Planella E; Perretti M; Suárez A
    PLoS One; 2013; 8(10):e76235. PubMed ID: 24155895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of genotype-phenotype relationships and stratification by the CARD15 variant genotype for inflammatory bowel disease susceptibility loci using multiple short tandem repeat genetic markers.
    Crawford NP; Colliver DW; Funke AA; Young MN; Kelley S; Cobbs GA; Petras RE; Galandiuk S
    Hum Mutat; 2005 Feb; 25(2):156-66. PubMed ID: 15643611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic variants in TNF-alpha but not DLG5 are associated with inflammatory bowel disease in a large United Kingdom cohort.
    Tremelling M; Waller S; Bredin F; Greenfield S; Parkes M
    Inflamm Bowel Dis; 2006 Mar; 12(3):178-84. PubMed ID: 16534418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New genes in inflammatory bowel disease: lessons for complex diseases?
    Gaya DR; Russell RK; Nimmo ER; Satsangi J
    Lancet; 2006 Apr; 367(9518):1271-84. PubMed ID: 16631883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostics of inflammatory bowel disease.
    Nikolaus S; Schreiber S
    Gastroenterology; 2007 Nov; 133(5):1670-89. PubMed ID: 17983810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review article: genetic susceptibility and application of genetic testing in clinical management of inflammatory bowel disease.
    Vermeire S
    Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():2-10. PubMed ID: 16961737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of IL23R, JAK2, and STAT3 gene polymorphisms and gene-gene interactions in Crohn's disease and ulcerative colitis in a Turkish population.
    Can G; Tezel A; Gürkan H; Tozkır H; Ünsal G; Soylu AR; Ümit HC
    Turk J Gastroenterol; 2016 Nov; 27(6):525-536. PubMed ID: 27852544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is it time to re-classify Crohn's disease?
    Fedorak RN
    Best Pract Res Clin Gastroenterol; 2004; 18 Suppl():99-106. PubMed ID: 15588801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.
    van der Linde K; Boor PP; Houwing-Duistermaat JJ; Crusius BJ; Wilson PJ; Kuipers EJ; de Rooij FW
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):449-59. PubMed ID: 17489054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The genetics and immunopathogenesis of inflammatory bowel disease.
    Cho JH
    Nat Rev Immunol; 2008 Jun; 8(6):458-66. PubMed ID: 18500230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attitudes toward genetic testing in patients with inflammatory bowel disease.
    Lal S; Appelton J; Mascarenhas J; Stempak JM; Esplen MJ; Silverberg MS
    Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):321-7. PubMed ID: 17353697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying Patients With Inflammatory Bowel Diseases in an Administrative Health Claims Database: Do Algorithms Generate Similar Findings?
    Ye Y; Manne S; Bennett D
    Inquiry; 2019; 56():46958019887816. PubMed ID: 31744340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetics of inflammatory bowel disease: the role of the HLA complex.
    Ahmad T; Marshall SE; Jewell D
    World J Gastroenterol; 2006 Jun; 12(23):3628-35. PubMed ID: 16773677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetics of inflammatory bowel disease: progress and prospects.
    Mathew CG; Lewis CM
    Hum Mol Genet; 2004 Apr; 13 Spec No 1():R161-8. PubMed ID: 14764625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Signal transducer and activator of transcription 6 gene G2964A polymorphism and inflammatory bowel disease.
    Xia B; Crusius JB; Wu J; Zwiers A; van Bodegraven AA; Peña AS
    Clin Exp Immunol; 2003 Mar; 131(3):446-50. PubMed ID: 12605697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 81.